𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: A prospective study

✍ Scribed by Dino Amadori; Annalisa Volpi; Roberta Maltoni; Oriana Nanni; Laura Amaducci; Andrea Amadori; Donata Casadei Giunchi; Antonio Vio; Ariele Saragoni; Rosella Silvestrini

Book ID
110229152
Publisher
Springer US
Year
1997
Tongue
English
Weight
33 KB
Volume
43
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Growth fraction as a predictor of respon
Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer
✍ Mohammed A. Aleskandarany; Andrew R. Green; Emad A. Rakha; Rabab A. Mohammed; So πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 218 KB

## Abstract Accurate predictive markers of chemotherapeutic response in early breast cancer are still lacking. The role of tumour growth fraction as a predictor of response to chemotherapy was assessed in early breast cancer. In this study, immunohistochemical expression of MIB1 was studied in a we

Osteoblastic metastatic disease as a the
Osteoblastic metastatic disease as a therapeutic response to adjuvant chemotherapy in breast cancer
✍ Angela L. Demartini; Aman U. Buzdar; George R. Blumenschein πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 262 KB

Included in this study were 43 breast cancer patients treated with adjuvant chemotherapy who presented metastasis only in bone. Forty-two percent had metastasis during chemotherapy, and 58% had metastasis after the completion of chemotherapy. In 66% of the patients, the lesions were osteolytic. Twen

Differential response to chemotherapy in
Differential response to chemotherapy in metastatic breast cancer in relation to estrogen receptor level. Results of a prospective randomized study
✍ Dutzu Rosner; Warren W. Lane; Takuma Nemoto πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 909 KB

The predictive value of estrogen receptor (ER) level for response to chemotherapy was studied in 182 patients with metastatic breast cancer in a prospective study. Patients were stratified according to ER status and dominant site of disease and randomized to one of three regimens: cyclophosphamide,

p53 mutations as a possible predictor of
p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas
✍ Jean Benhattar; Jean-Philippe Cerottini; Emilia Saraga; GeneviΓ¨ve Metthez; Jean- πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 310 KB πŸ‘ 2 views

Although intrahepatic infusion therapy with 5-fluorouracil for unresectable colorectal liver metastases may lead to improved overall survival for some patients, it is not clear why a response is not observed in others. Gene alterations in oncogenes or tumor-suppressor genes are critical events in tu